BB Biotech's Q3 Profit, Operating Income Down

02:00 AM EDT, 10/23/2026 (MT Newswires) -- BB Biotech (BION.SW) logged 175 million francs in profit for the third quarter, compared with 447.6 million francs a year ago. EPS moved to 3.17 francs from 8.16 francs year over year, a Friday filing showed. For the three months ended Sept. 30, operating income was 185.8 million francs versus 455.4 million francs previously, the Swiss biotechnology investment company added.